Results 141 to 150 of about 79,811 (267)

A Clinical Guidance for the Management of Patients With Hepatoid Adenocarcinoma and A Case Series

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Hepatoid adenocarcinoma (HAC) is a rare extrahepatic tumor of non‐germ cell origin that morphologically resembles hepatocellular carcinoma (HCC). HAC has a propensity to metastasize to the liver and therefore may be mistaken for HCC. There is a lack of standardized treatment protocols, and further studies are needed to evaluate the benefit of ...
Christina Liava, Sudhakar Venkatesh, Michael S. Torbenson, Patrick S. Kamath, Moira Hilscher   +4 more
wiley   +1 more source

Cloning of the genetopA encoding for DNA topoisomerase 1 and the physical mapping of thecysB–topA–trpAregion ofEscherichia colt [PDF]

, 1983
James C. Wang, Kathleen Becherer
openalex   +1 more source

Figure S6 from A Novel Inhibitor of Topoisomerase I Is Selectively Toxic for a Subset of Non–Small Cell Lung Cancer Cell Lines

, 2023
Iryna O. Zubovych, Anirudh Sethi, Aditya Kulkarni, Vural Tagal, Michael G. Roth   +4 more
openalex   +1 more source

Therapy‐Related Acute Myeloid Leukemia Following Plasma Cell Leukemia: A Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT With the improvement of survival in multiple myeloma (MM), therapy‐related acute myeloid leukemia (t‐AML) has emerged as a clinically relevant second primary malignancy (SPM). We report a case of MM evolving into t‐AML after multi‐agent chemotherapy and review the literature on therapy‐related leukemias in MM.
Songdi Chen, Junqing Hu, Qian Zhang, Luling Mao, Qian Jiang, Chuyun Qian, Weize Zhang, Keting Jin, Jianhu Li, Ji‐nuo Wang, Yi Zhao   +10 more
wiley   +1 more source

Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen <i>Bacillus anthracis</i> and Its Type II Topoisomerases. [PDF]

ACS Infect Dis
Mann CA, Halasohoris SA, Gray AM, Chua J, Spencer JL, Curry BJ, Babyak AL, Klimko CP, Cote CK, West JS, Mitton-Fry MJ, Meinig JM, Osheroff N.   +12 more
europepmc   +1 more source

A Novel Inhibitor of Topoisomerase I Is Selectively Toxic for a Subset of Non–Small Cell Lung Cancer Cell Lines

, 2015
Iryna O. Zubovych, Anirudh Sethi, Aditya Kulkarni, Vural Tagal, Michael G. Roth   +4 more
openalex   +1 more source

Safety and Efficacy of Concomitant Administration of Nanoliposomal Irinotecan + 5‐Fluorouracil/Levo‐Leucovorin for Pancreatic Cancer

Cancer Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background Nanoliposomal irinotecan (nal‐IRI) plus 5‐fluorouracil (5‐FU)/levo‐leucovorin (Levo‐LV) therapy is recommended as the standard of care for unresectable locally advanced (UR‐LA) and metastatic pancreatic cancer after failure of gemcitabine‐containing regimens.
Akane Wakabayashi, Rei Tanaka, Yurie Fukumuro, Keita Mori, Junya Sato, Hiroshi Ishikawa, Michihiro Shino, Takeshi Kawakami   +7 more
wiley   +1 more source

Cladosporium cladosporioides, endophyte of Strelitzia nicolai, as a new producer of Alternariol monomethyl ether with a potential cytotoxic activity. [PDF]

Sci Rep
Farag NM, El-Sayed ASA, Fikry E, Tawfeek N, El-Shafae AM, El-Domiaty MM.   +5 more
europepmc   +1 more source

Virtual Screening and ADMET Studies of Phytomolecules Targeting DNA Topoisomerase II

, 2017
Yogesh Kumar, Feroz Khan, Laiq ur Rahman
openalex   +1 more source

Topoisomerase inhibitors suppressed lithocholic acid-induced promotion of transformation in BALB/3T3 [PDF]

, 1987
Motohisa Kaneko, Junko Horikoshi
openalex   +1 more source